BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sato K, Hall C, Glaser S, Francis H, Meng F, Alpini G. Pathogenesis of Kupffer Cells in Cholestatic Liver Injury. Am J Pathol. 2016;186:2238-2247. [PMID: 27452297 DOI: 10.1016/j.ajpath.2016.06.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Li M, Cai SY, Boyer JL. Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. 2017;56:45-53. [PMID: 28606651 DOI: 10.1016/j.mam.2017.06.001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 20.0] [Reference Citation Analysis]
2 闫洪锋, 孙宏伟, 王平, 张诗琳, 杨建武, 徐冰心, 周金莲, 李成林, 崔彦. 脂多糖对高糖环境下肝脏Kupffer细胞增殖和分泌及超微结构的影响. 世界华人消化杂志 2017; 25(5): 412-419 [DOI: 10.11569/wcjd.v25.i5.412] [Reference Citation Analysis]
3 Arsenijevic A, Stojanovic B, Milovanovic J, Arsenijevic D, Arsenijevic N, Milovanovic M. Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development. Int J Mol Sci 2020;21:E5097. [PMID: 32707678 DOI: 10.3390/ijms21145097] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Zheng Y, Cui B, Sun W, Wang S, Huang X, Gao H, Gao F, Cheng Q, Lu L, An Y, Li X, Sun N. Potential Crosstalk between Liver and Extra-liver Organs in Mouse Models of Acute Liver Injury. Int J Biol Sci 2020;16:1166-79. [PMID: 32174792 DOI: 10.7150/ijbs.41293] [Reference Citation Analysis]
5 Boeri L, Izzo L, Sardelli L, Tunesi M, Albani D, Giordano C. Advanced Organ-on-a-Chip Devices to Investigate Liver Multi-Organ Communication: Focus on Gut, Microbiota and Brain. Bioengineering (Basel) 2019;6:E91. [PMID: 31569428 DOI: 10.3390/bioengineering6040091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
6 Tegge AN, Rodrigues RR, Larkin AL, Vu L, Murali TM, Rajagopalan P. Transcriptomic Analysis of Hepatic Cells in Multicellular Organotypic Liver Models. Sci Rep 2018;8:11306. [PMID: 30054499 DOI: 10.1038/s41598-018-29455-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xiong X, Ren Y, Cui Y, Li R, Wang C, Zhang Y. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation. Biomed Pharmacother. 2017;96:1292-1298. [PMID: 29174575 DOI: 10.1016/j.biopha.2017.11.083] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
8 Tian L, Li W, Yang L, Chang N, Fan X, Ji X, Xie J, Yang L, Li L. Cannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1 Macrophage Polarization via RhoA/NF-κB p65 and ERK1/2 Pathways, Respectively, in Mouse Liver Fibrogenesis. Front Immunol 2017;8:1214. [PMID: 29033935 DOI: 10.3389/fimmu.2017.01214] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
9 Fu HY, Bao WM, Yang CX, Lai WJ, Xu JM, Yu HY, Yang YN, Tan X, Gupta AK, Tang YM. Kupffer Cells Regulate Natural Killer Cells Via the NK group 2, Member D (NKG2D)/Retinoic Acid Early Inducible-1 (RAE-1) Interaction and Cytokines in a Primary Biliary Cholangitis Mouse Model. Med Sci Monit 2020;26:e923726. [PMID: 32599603 DOI: 10.12659/MSM.923726] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Arsenijevic A, Stojanovic B, Milovanovic J, Arsenijevic D, Arsenijevic N, Milovanovic M. Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development. Int J Mol Sci. 2020;21:5097. [PMID: 32707678 DOI: 10.1038/s41575-019-0226-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 33.0] [Reference Citation Analysis]
11 Taylor SA, Chen SY, Gadhvi G, Feng L, Gromer KD, Abdala-Valencia H, Nam K, Dominguez ST, Montgomery AB, Reyfman PA, Ostilla L, Wechsler JB, Cuda CM, Green RM, Perlman H, Winter DR. Transcriptional profiling of pediatric cholestatic livers identifies three distinct macrophage populations. PLoS One 2021;16:e0244743. [PMID: 33411796 DOI: 10.1371/journal.pone.0244743] [Reference Citation Analysis]
12 Lee JH, Kim JH, Lee S, Han JK. Monitoring of impaired phagocytic function of Kupffer cells in an obstructive cholangitis rat model using superparamagnetic iron oxide MRI and contrast-enhanced ultrasound. Acta Radiol 2019;60:407-14. [PMID: 30724596 DOI: 10.1177/0284185118784978] [Reference Citation Analysis]
13 Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
14 Guillot A, Tacke F. Liver Macrophages: Old Dogmas and New Insights. Hepatol Commun 2019;3:730-43. [PMID: 31168508 DOI: 10.1002/hep4.1356] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 53.0] [Reference Citation Analysis]
15 Colino CI, Lanao JM, Gutierrez-Millan C. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles. Front Immunol 2020;11:218. [PMID: 32194546 DOI: 10.3389/fimmu.2020.00218] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
16 Zhang W, Li X, Liu Y, Chen H, Gong J. Activation of imidazoline I 1 receptor by moxonidine regulates the progression of liver fibrosis in the Nrf2-dependent pathway. Biomedicine & Pharmacotherapy 2017;90:821-34. [DOI: 10.1016/j.biopha.2017.04.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Fabris L, Sato K, Alpini G, Strazzabosco M. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology 2021;73 Suppl 1:75-85. [PMID: 32500550 DOI: 10.1002/hep.31410] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
18 Lu TF, Yang TH, Zhong CP, Shen C, Lin WW, Gu GX, Xia Q, Xu N. Dual Effect of Hepatic Macrophages on Liver Ischemia and Reperfusion Injury during Liver Transplantation. Immune Netw 2018;18:e24. [PMID: 29984042 DOI: 10.4110/in.2018.18.e24] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
19 Yokoda RT, Rodriguez EA. Review: Pathogenesis of cholestatic liver diseases. World J Hepatol 2020; 12(8): 423-435 [PMID: 32952871 DOI: 10.4254/wjh.v12.i8.423] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
20 Yang Y, Zhao Y, Zhang L, Zhang F, Li L. The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues. Front Med (Lausanne) 2021;8:655268. [PMID: 34136500 DOI: 10.3389/fmed.2021.655268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2018;10:133-148. [PMID: 30186577 DOI: 10.15171/mejdd.2018.103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
22 Sato K, Kennedy L, Liangpunsakul S, Kusumanchi P, Yang Z, Meng F, Glaser S, Francis H, Alpini G. Intercellular Communication between Hepatic Cells in Liver Diseases. Int J Mol Sci 2019;20:E2180. [PMID: 31052525 DOI: 10.3390/ijms20092180] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
23 Tasnim F, Xing J, Huang X, Mo S, Wei X, Tan M, Yu H. Generation of mature kupffer cells from human induced pluripotent stem cells. Biomaterials 2019;192:377-91. [DOI: 10.1016/j.biomaterials.2018.11.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
24 Cai SY, Ge M, Mennone A, Hoque R, Ouyang X, Boyer JL. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse. Cell Mol Gastroenterol Hepatol 2020;9:679-88. [PMID: 31887435 DOI: 10.1016/j.jcmgh.2019.12.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
25 Wang L, Xu D, Li L, Xing X, Liu L, Ismail Abdelmotalab M, Xiao L, Pang T, Huang X, Wang X, Wang T, Jiang Z, Zhang L, Sun L. Possible role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicity. Toxicology Letters 2018;299:32-9. [DOI: 10.1016/j.toxlet.2018.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
26 Yong L, Li M, Gao Y, Deng Y, Liu W, Huang D, Ren C, Liu M, Shen J, Hou X. Identification of pro-inflammatory CD205+ macrophages in livers of hepatitis B virus transgenic mice and patients with chronic hepatitis B. Sci Rep 2017;7:46765. [PMID: 28436459 DOI: 10.1038/srep46765] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
27 Mihm S. Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver. Int J Mol Sci 2018;19:E3104. [PMID: 30309020 DOI: 10.3390/ijms19103104] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 17.0] [Reference Citation Analysis]
28 Sun X, Ye C, Deng Q, Chen J, Guo C. Contribution of glutaredoxin-1 to Fas s-glutathionylation and inflammation in ethanol-induced liver injury. Life Sci 2021;264:118678. [PMID: 33127518 DOI: 10.1016/j.lfs.2020.118678] [Reference Citation Analysis]
29 Hayashi K, Maruhashi T, Sakamoto W, Yogo T. Organic-Inorganic Hybrid Hollow Nanoparticles Suppress Oxidative Stress and Repair Damaged Tissues for Treatment of Hepatic Fibrosis. Adv Funct Mater 2018;28:1706332. [DOI: 10.1002/adfm.201706332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
30 Wu N, McDaniel K, Zhou T, Ramos-Lorenzo S, Wu C, Huang L, Chen D, Annable T, Francis H, Glaser S, Alpini G, Meng F. Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-κB signaling pathway in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2018;315:G385-98. [PMID: 29848019 DOI: 10.1152/ajpgi.00111.2018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
31 Sato K, Meng F, Giang T, Glaser S, Alpini G. Mechanisms of cholangiocyte responses to injury. Biochim Biophys Acta Mol Basis Dis 2018;1864:1262-9. [PMID: 28648950 DOI: 10.1016/j.bbadis.2017.06.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
32 Mahmoudi J, Mahmoodpoor A, Amirnia M, Kazemi T, Chokhachi Baradaran P, Sheikh Najafi S, Sadigh‐eteghad S, Farajdokht F, Xu H, Belalzadeh M, Sandoghchian Shotorbani S. The induced decrease in TLR2 and TLR4 by cerebrolysin in the alcoholic liver of rats. J Cell Physiol 2019;234:16290-4. [DOI: 10.1002/jcp.28293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Fiste O, Ntanasis-Stathopoulos I, Gavriatopoulou M, Liontos M, Koutsoukos K, Dimopoulos MA, Zagouri F. The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma. Vaccines (Basel) 2021;9:422. [PMID: 33922362 DOI: 10.3390/vaccines9050422] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Sato K, Meng F, Fava G, Glaser S, Alpini G. Functional roles of gut bacteria imbalance in cholangiopathies. Liver Research 2019;3:40-5. [DOI: 10.1016/j.livres.2018.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
35 Zhang X, Li X, Xiong P, Yi C, Chen X. [Effects of Panax notoginseng saponins on liver graft rejection in rats and the mechanisms]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:394-400. [PMID: 31068281 DOI: 10.12122/j.issn.1673-4254.2019.04.03] [Reference Citation Analysis]
36 Cai SY, Boyer JL. The role of bile acids in cholestatic liver injury. Ann Transl Med 2021;9:737. [PMID: 33987435 DOI: 10.21037/atm-20-5110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Sato K, Glaser S, Kennedy L, Liangpunsakul S, Meng F, Francis H, Alpini G. Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets. Expert Opin Ther Targets 2019;23:461-72. [PMID: 30990740 DOI: 10.1080/14728222.2019.1608950] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
38 Zhang D, Zhang C, Wang J, Wang B, Wang H, Zhang Z, Chen Y, Lu Y, Tao L, Wang J, Chen X, Xu D. Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation. Toxicology and Applied Pharmacology 2017;314:39-47. [DOI: 10.1016/j.taap.2016.11.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
39 Li Q, Che F, Wei Y, Jiang HY, Zhang Y, Song B. Role of noninvasive imaging in the evaluation of intrahepatic cholangiocarcinoma: from diagnosis and prognosis to treatment response. Expert Rev Gastroenterol Hepatol 2021;15:1267-79. [PMID: 34452581 DOI: 10.1080/17474124.2021.1974294] [Reference Citation Analysis]